Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Clinical trial NCT05403723 · SUSPENDED

Trial details

NCT number: NCT05403723
Sponsor: University of Maryland, Baltimore
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Extensive-stage Small-cell Lung Cancer

Start date: 2026-06-30
Primary completion: 2027-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.